BACKGROUND: Chronic respiratory disease represents an important comorbidity for persons living with HIV (PLWH). HIV itself is associated with greater impairment in lung function. We aimed to determine the association between declining lung function and both quality of life (QOL) and health care utilization for PLWH. METHODS: Using longitudinal data from the Study of HIV Infection in the Etiology of Lung Disease 2009-2017, we studied the association between changes in lung function and both QOL and acute care events (emergency department visit or hospitalization). The Medical Outcomes Studies-HIV Questionnaire provided QOL domains. Multivariable regression models were performed with generalized estimating equations accounting for 1499 participants, 485 with HIV, contributing 10,825 spirometry visits. RESULTS: Among PLWH, decreased FEV1 was associated with worse physical health for those with higher viral load [β: -1.66, 95% confidence interval (CI): -3.11 to -0.39] compared to those with viral suppression (β: -0.58, 95% CI: -1.06 to -0.162), even in those without airflow obstruction. Lower FEV1 was also associated with increased odds of both emergency department (odds ratio: 1.21, 95% CI: 1.09 to 1.34) and inpatient (odds ratio: 1.26, 95% CI: 1.12 to 1.42) hospitalizations for PLWH. Lung function was not associated with increased odds of acute care events for HIV-uninfected participants. CONCLUSIONS: FEV1 declines represent an independent predictor of QOL and acute care events among PLWH. Although the generalizability of these results may be limited, because of the high-risk population included, findings suggest that care for PLWH should involve monitoring FEV1 over time, especially in those with poor virologic control, with emphasis on the development and implementation of interventions to mitigate lung function decline.
BACKGROUND: Chronic respiratory disease represents an important comorbidity for persons living with HIV (PLWH). HIV itself is associated with greater impairment in lung function. We aimed to determine the association between declining lung function and both quality of life (QOL) and health care utilization for PLWH. METHODS: Using longitudinal data from the Study of HIV Infection in the Etiology of Lung Disease 2009-2017, we studied the association between changes in lung function and both QOL and acute care events (emergency department visit or hospitalization). The Medical Outcomes Studies-HIV Questionnaire provided QOL domains. Multivariable regression models were performed with generalized estimating equations accounting for 1499 participants, 485 with HIV, contributing 10,825 spirometry visits. RESULTS: Among PLWH, decreased FEV1 was associated with worse physical health for those with higher viral load [β: -1.66, 95% confidence interval (CI): -3.11 to -0.39] compared to those with viral suppression (β: -0.58, 95% CI: -1.06 to -0.162), even in those without airflow obstruction. Lower FEV1 was also associated with increased odds of both emergency department (odds ratio: 1.21, 95% CI: 1.09 to 1.34) and inpatient (odds ratio: 1.26, 95% CI: 1.12 to 1.42) hospitalizations for PLWH. Lung function was not associated with increased odds of acute care events for HIV-uninfected participants. CONCLUSIONS: FEV1 declines represent an independent predictor of QOL and acute care events among PLWH. Although the generalizability of these results may be limited, because of the high-risk population included, findings suggest that care for PLWH should involve monitoring FEV1 over time, especially in those with poor virologic control, with emphasis on the development and implementation of interventions to mitigate lung function decline.
Authors: Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris Journal: Ann Am Thorac Soc Date: 2018-02
Authors: Sebastiaan O Verboeket; Ferdinand W Wit; Greg D Kirk; M Bradley Drummond; Reindert P van Steenwijk; Rosan A van Zoest; Jeannine F Nellen; Maarten F Schim van der Loeff; Peter Reiss Journal: J Infect Dis Date: 2019-04-08 Impact factor: 5.226
Authors: Gerard J Criner; Richard Sue; Shawn Wright; Mark Dransfield; Hiram Rivas-Perez; Tanya Wiese; Frank C Sciurba; Pallav L Shah; Momen M Wahidi; Hugo Goulart de Oliveira; Brian Morrissey; Paulo F G Cardoso; Steven Hays; Adnan Majid; Nicholas Pastis; Lisa Kopas; Mark Vollenweider; P Michael McFadden; Michael Machuzak; David W Hsia; Arthur Sung; Nabil Jarad; Malgorzata Kornaszewska; Stephen Hazelrigg; Ganesh Krishna; Brian Armstrong; Narinder S Shargill; Dirk-Jan Slebos Journal: Am J Respir Crit Care Med Date: 2018-11-01 Impact factor: 21.405
Authors: Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks Journal: Eur Respir J Date: 2012-06-27 Impact factor: 16.671
Authors: Keri N Althoff; Kelly A Gebo; Richard D Moore; Cynthia M Boyd; Amy C Justice; Cherise Wong; Gregory M Lucas; Marina B Klein; Mari M Kitahata; Heidi Crane; Michael J Silverberg; M John Gill; William Christopher Mathews; Robert Dubrow; Michael A Horberg; Charles S Rabkin; Daniel B Klein; Vincent Lo Re; Timothy R Sterling; Fidel A Desir; Kenneth Lichtenstein; James Willig; Anita R Rachlis; Gregory D Kirk; Kathryn Anastos; Frank J Palella; Jennifer E Thorne; Joseph Eron; Lisa P Jacobson; Sonia Napravnik; Chad Achenbach; Angel M Mayor; Pragna Patel; Kate Buchacz; Yuezhou Jing; Stephen J Gange Journal: Lancet HIV Date: 2019-01-22 Impact factor: 12.767
Authors: Cristine E Berry; M Bradley Drummond; MeiLan K Han; Daner Li; Cathy Fuller; Andrew H Limper; Fernando J Martinez; Marvin I Schwarz; Frank C Sciurba; Robert A Wise Journal: Chest Date: 2012-09 Impact factor: 9.410
Authors: Trishul Siddharthan; Matthew R Grigsby; Dina Goodman; Muhammad Chowdhury; Adolfo Rubinstein; Vilma Irazola; Laura Gutierrez; J Jaime Miranda; Antonio Bernabe-Ortiz; Dewan Alam; Bruce Kirenga; Rupert Jones; Frederick van Gemert; Robert A Wise; William Checkley Journal: Am J Respir Crit Care Med Date: 2018-03-01 Impact factor: 30.528
Authors: Emily S Wan; Peter J Castaldi; Michael H Cho; John E Hokanson; Elizabeth A Regan; Barry J Make; Terri H Beaty; MeiLan K Han; Jeffrey L Curtis; Douglas Curran-Everett; David A Lynch; Dawn L DeMeo; James D Crapo; Edwin K Silverman Journal: Respir Res Date: 2014-08-06
Authors: Sarath Raju; Jacquie Astemborski; Michael Bradley Drummond; Hema C Ramamurthi; Jing Sun; Robert H Brown; Gregory D Kirk; Meredith C McCormack Journal: J Acquir Immune Defic Syndr Date: 2022-01-01 Impact factor: 3.771